Case AS - Search Results

1

Clustering of Lynch syndrome malignancies with no evidence for a role of DNA mismatch repair.

Case AS, Zighelboim I, Mutch DG, Babb SA, Schmidt AP, Whelan AJ, Thibodeau SN, Goodfellow PJ. Case AS, et al. Gynecol Oncol. 2008 Feb;108(2):438-44. doi: 10.1016/j.ygyno.2007.09.036. Epub 2007 Nov 26. Gynecol Oncol. 2008. PMID: 18022218 Free PMC article.

2

Wound complications after gynecologic cancer surgery.

Nugent EK, Hoff JT, Gao F, Massad LS, Case A, Zighelboim I, Mutch DG, Thaker PH. Nugent EK, et al. Gynecol Oncol. 2011 May 1;121(2):347-52. doi: 10.1016/j.ygyno.2011.01.026. Epub 2011 Feb 15. Gynecol Oncol. 2011. PMID: 21324517

3

The role of PET/CT in the management of patients with cervical cancer: practice patterns of the members of the Society of Gynecologic Oncologists.

Kizer NT, Zighelboim I, Case AS, Dewdney SB, Thaker PH, Massad LS. Kizer NT, et al. Among authors: case as. Gynecol Oncol. 2009 Aug;114(2):310-4. doi: 10.1016/j.ygyno.2009.04.018. Epub 2009 May 14. Gynecol Oncol. 2009. PMID: 19446317

4

The value of perioperative imaging in patients with uterine sarcomas.

Nugent EK, Zighelboim I, Case AS, Gao F, Thaker PH, Rader JS, Mutch DG, Massad LS. Nugent EK, et al. Among authors: case as. Gynecol Oncol. 2009 Oct;115(1):37-40. doi: 10.1016/j.ygyno.2009.06.013. Epub 2009 Jul 4. Gynecol Oncol. 2009. PMID: 19577795 Free PMC article.

5

Chemoradiation in locally advanced cervical carcinoma: an analysis of cisplatin dosing and other clinical prognostic factors.

Nugent EK, Case AS, Hoff JT, Zighelboim I, DeWitt LL, Trinkhaus K, Mutch DG, Thaker PH, Massad LS, Rader JS. Nugent EK, et al. Among authors: case as. Gynecol Oncol. 2010 Mar;116(3):438-41. doi: 10.1016/j.ygyno.2009.09.045. Epub 2009 Nov 5. Gynecol Oncol. 2010. PMID: 19896180

6

"Surgical Apgar Score" predicts postoperative complications after cytoreduction for advanced ovarian cancer.

Zighelboim I, Kizer N, Taylor NP, Case AS, Gao F, Thaker PH, Rader JS, Massad LS, Mutch DG, Powell MA. Zighelboim I, et al. Among authors: case as. Gynecol Oncol. 2010 Mar;116(3):370-3. doi: 10.1016/j.ygyno.2009.11.031. Epub 2009 Dec 16. Gynecol Oncol. 2010. PMID: 20015540

7

Multicenter phase II trial of topotecan, cisplatin and bevacizumab for recurrent or persistent cervical cancer.

Zighelboim I, Wright JD, Gao F, Case AS, Massad LS, Mutch DG, Powell MA, Thaker PH, Eisenhauer EL, Cohn DE, Valea FA, Alvarez Secord A, Lippmann LT, Dehdashti F, Rader JS. Zighelboim I, et al. Among authors: case as. Gynecol Oncol. 2013 Jul;130(1):64-8. doi: 10.1016/j.ygyno.2013.04.009. Epub 2013 Apr 13. Gynecol Oncol. 2013. PMID: 23591400 Free PMC article. Clinical Trial.

8

Malignant melanoma of the vulva: an extension of cutaneous melanoma?

Moxley KM, Fader AN, Rose PG, Case AS, Mutch DG, Berry E, Schink JC, Kim CH, Chi DS, Moore KN. Moxley KM, et al. Among authors: case as. Gynecol Oncol. 2011 Sep;122(3):612-7. doi: 10.1016/j.ygyno.2011.04.007. Epub 2011 May 14. Gynecol Oncol. 2011. PMID: 21570710

9

Clinical and pathologic features of vulvar intraepithelial neoplasia in premenopausal and postmenopausal women.

Nugent EK, Brooks RA, Barr CD, Case AS, Mutch DG, Massad LS. Nugent EK, et al. Among authors: case as. J Low Genit Tract Dis. 2011 Jan;15(1):15-9. doi: 10.1097/LGT.0b013e3181ee2598. J Low Genit Tract Dis. 2011. PMID: 21192171

10

A cost-effectiveness analysis of chemotherapy for patients with recurrent platinum-sensitive epithelial ovarian cancer.

Case AS, Rocconi RP, Partridge EE, Straughn JM Jr. Case AS, et al. Gynecol Oncol. 2007 Apr;105(1):223-7. doi: 10.1016/j.ygyno.2006.11.018. Epub 2007 Jan 9. Gynecol Oncol. 2007. PMID: 17215031

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

44 results

Search Page

Filters